EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”), today announced the pricing of its underwritten public offering of 3,200,380 shares of common stock (or pre-funded warrants in lieu th…
Category: Business
National Vision Holdings, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024 and will host a conference call a…
National Vision Announces Optometry Students Selected to Win $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced the winners of its 2024 National Optometric Student Association (NOSA) scholarships. Throug…
CenterWell Announces Plans to Open 23 Senior Primary Care Centers at Walmart Locations in Florida, Georgia, Missouri and Texas
LOUISVILLE, Ky.–(BUSINESS WIRE)–CenterWell, the health care services business of Humana Inc. (NYSE: HUM), today announced plans to lease clinical space and open senior-focused primary care centers at 23 Walmart Supercenter retail stores in Florida, G…
GenSight Biologics Reports Cash Position as of June 30, 2024, and Provides Business Update
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics publie sa position de trésorerie au 30 juin 2024, et fait le point sur ses activités
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodé…
Spryte Medical Receives Breakthrough Device Designation from FDA for Revolutionary neuro Optical Coherence Tomography (nOCT) Technology
BEDFORD, Mass.–(BUSINESS WIRE)–Spryte Medical, a pioneering company in advanced medical imaging technologies, proudly announces that its neuro Optical Coherence Tomography (nOCT) technology has been granted Breakthrough Device Designation by the U.S….
Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research
BOSTON & CHICAGO–(BUSINESS WIRE)– #Innovation–Leading Ophthalmic CRO Ora announces recapitalization by The Vistria Group, New CEO Paul Colvin
New Data for Genentech’s Susvimo Demonstrates Sustained Efficacy in Two Serious Diabetic Eye Conditions
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo® (ranibizumab injection) 100 mg/mL for th…
Perry J. Sternberg Joins Sydnexis as Chief Executive Officer
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis, Inc., (www.sydnexis.com) a pre-commercial stage biopharmaceutical company focused on the treatment of progression of pediatric myopia, is excited to announce the appointment of Perry J. Sternberg as Chief Exe…
En partenariat avec EnChroma et la Fondation Paolina Brugnatelli, Ravenne, la capitale mondiale des mosaïques inscrite au patrimoine mondial de l’UNESCO, offre aux visiteurs daltoniens la possibilité de découvrir la couleur de ses mosaïques
RAVENNE, Italie–(BUSINESS WIRE)–L’Opera di Religione della Diocesi di Ravenna, EnChroma, fabricants de lunettes optiques pour daltoniens, Francesca Carlone, designer durable et initiatrice du projet, la Fondation Paolina Brugnatelli et ITRIA annoncen…
Ravenna, die Stadt der Mosaike, UNESCO-Weltkulturerbe, ermöglicht in Zusammenarbeit mit EnChroma und der Fondazione Paolina Brugnatelli farbenblinden Besuchern, die Farben der Mosaike neu zu entdecken
RAVENNA, Italien–(BUSINESS WIRE)– #enchroma–Opera di Religione della Diocesi di Ravenna, EnChroma, Hersteller von Linsen für farbenblinde Menschen, Francesca Carlone, nachhaltige Designerin und Gründerin des Projekts, Fondazione Paolina Brugnatelli …
Ravenna, City of Mosaics, UNESCO World Heritage Site, in Partnership with EnChroma and Fondazione Paolina Brugnatelli, Enables Color Blind Visitors to Rediscover the Colors of Mosaics
RAVENNA, Italy–(BUSINESS WIRE)– #enchroma–Opera di Religione della Diocesi di Ravenna, EnChroma, manufacturers of lenses for color blind users, Francesca Carlone, sustainable designer and founder of the project, Fondazione Paolina Brugnatelli and IT…
Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CastleBiosciences–Castle will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024
Ravenna, città del mosaico, riconosciuta Patrimonio Mondiale dall’UNESCO, in collaborazione con EnChroma e Fondazione Paolina Brugnatelli permette ai visitatori daltonici di riscoprire i colori dei mosaici
RAVENNA, Italy–(BUSINESS WIRE)–Ravenna, città del mosaico, riconosciuta Patrimonio Mondiale dall’UNESCO, permette ai visitatori daltonici di riscoprire i colori dei mosaici
Merck Completes Acquisition of EyeBio
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). EyeBio is now a wholly-owned subsidiary of Merck. “The EyeBio acqu…
Ophthalmics Partnering Agreements Analysis Report and Directory 2019-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmics Collaboration and Licensing Deals 2019-2024” report has been added to ResearchAndMarkets.com’s offering. Fully revised and updated, the report provides details of ophthalmics deals from 2019 to 2024. Ophthalmic…
Castle Biosciences Honored with Top Workplaces Awards
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CastleBiosciences–Castle honored as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) announces preliminary net revenue for the second quarter of 2024 of $2.4 million and for the first half of 2024 of $5.0 million, primar…
GenSight Biologics lance une lettre d'information pour les investisseurs particuliers
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…